John McKey Net Worth

The estimated Net Worth of John D Jr Mckey is at least $1.71 Million dollars as of 14 March 2012. Mr. Mckey owns over 26,411 units of iBio Inc stock worth over $1,649,740 and over the last 13 years he sold IBIO stock worth over $62,539. In addition, he makes $19 as Independent Director at iBio Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. McKey IBIO stock SEC Form 4 insiders trading

John has made over 4 trades of the iBio Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 26,411 units of IBIO stock worth $26,147 on 14 March 2012.

The largest trade he's ever made was buying 100,000 units of iBio Inc stock on 13 January 2012 worth over $65,000. On average, John trades about 13,291 units every 5 days since 2011. As of 14 March 2012 he still owns at least 868,284 units of iBio Inc stock.

You can see the complete history of Mr. Mckey stock trades at the bottom of the page.

John McKey biography

John D. McKey Jr. serves as Independent Director of the Company. Mr. McKey has served as a member of our Board since we became a publicly traded company in August 2008. He has also served as of counsel at McCarthy, Summers, Bobko, Wood, Sawyer & Perry, P.A. (“McCarthy”) in Stuart, Florida from 2003 until 2016 and is now retired. He previously was a partner of McCarthy from 1987 through 2003. From 1977 to 1987, Mr. McKey was a partner at Gunster Yoakley in Palm Beach, Florida. Mr. McKey received his B.B.A at the University of Georgia and his J.D. from the University of Florida College of Law. Mr. McKey’s extensive experience representing private and public companies operating in varied business sectors brings our Board insights and acumen to best corporate practices and implementation of strategic and financial plans.

What is the salary of John McKey?

As the Independent Director of iBio Inc, the total compensation of John McKey at iBio Inc is $19. There are 8 executives at iBio Inc getting paid more, with Thomas Isett having the highest compensation of $1,784,020.

How old is John McKey?

John McKey is 77, he's been the Independent Director of iBio Inc since 2008. There are 3 older and 12 younger executives at iBio Inc. The oldest executive at iBio Inc is Seymour Flug, 84, who is the Independent Director.

What's John McKey's mailing address?

John's mailing address filed with the SEC is C/O IBIO, INC., 8800 HSC PARKWAY, BRYAN, TX, 77807.

Insiders trading at iBio Inc

Over the last 14 years, insiders at iBio Inc have traded over $99,626,328 worth of iBio Inc stock and bought 15,716,013 units worth $10,660,994 . The most active insiders traders include Capital Ltd Portfolio Servi..., Carl Desantis, and William D Clark. On average, iBio Inc executives and independent directors trade stock every 98 days with the average trade being worth of $1,893,515. The most recent stock trade was executed by Martin Brenner on 1 November 2023, trading 4,881 units of IBIO stock currently worth $1,318.

What does iBio Inc do?

ibio is a contract development and manufacturing organization equipped to take clients from the early stages of product selection through regulatory approval and commercial product launch. ibio’s technology platform and facility capabilities are applicable to the development of biotherapeutics, vaccines, diagnostic products, and certain types of medical devices – and often provide significant time and value advantages over traditional approaches. ibio’s lab to launch capabilities assure the most rapid manufacturing support to reach the clinic. ibio’s team is comprised of knowledgeable protein scientists, microbiologists and manufacturing and regulatory experts, all of whom add significant expertise and value throughout the entire process. the same team and facility that produces preclinical and clinical material will be the same team producing your product for market launch; contributing to the seamless scale-up process the ibio technology platform creates.

Complete history of Mr. Mckey stock trades at iBio Inc

iBio Inc executives and stock owners

iBio Inc executives and other stock owners filed with the SEC include:

• Thomas Isett,
  Chairman of the Board, Chief Executive Officer
• Thomas F. Isett III,
  CEO, Pres & Chairman
• Robert Kay,
  Interim Secretary, Interim Treasurer, Director
• Randy Joe Maddux,
  Chief Operating Officer
• Dr. Martin B. Brenner D.V.M., Ph.D.,
  Chief Scientific Officer
• Robert Erwin,
  President
• Robert B. Kay,
  Interim Sec. & Interim Treasurer
• James Hill,
  Independent Director
• John McKey,
  Independent Director
• Seymour Flug,
  Independent Director
• Glenn Chang,
  Independent Director
• Stephen Kilmer,
  Investor Relations
• Gary Sender,
  Independent Director
• Alexandra Kropotova,
  Independent Director
• Linda Armstrong,
  Independent Director
• John Delta,
  Principal Financial Officer, Principal Accounting Officer
• Carlos Picosse,
  Chief Exec. Officer of IBio Brazil
• Dr. Melissa Berquist Ph.D.,
  VP and Head of Vaccines & Animal Health
• Lisa Middlebrook,
  Chief HR Officer
• Robert Matthew Lutz,
  Chief Financial & Bus. Officer
• Mark A Giannone,
  Chief Financial Officer
• Kenneth Bryan Dart,
  10% owner
• Carl Desantis,
  10% owner
• Philip K. Russell,
  Director
• Arthur Y Elliott,
  Director
• Capital Ltd Portfolio Servi...,
  
• Ryan E Terence,
  Chief Scientific Officer
• Randy Joe Maddux,
  Chief Operating Officer
• Robert Matthew Lutz,
  See Remarks
• James P. Mullaney,
  Chief Financial Officer
• Evert B. Schimmelpennink,
  Director
• E Gerald Kay,
  10% owner
• Jules A. Musing,
  Director
• William D Clark,
  Director
• Martin Brenner,
  See Remarks
• Felipe Duran,
  Chief Financial Officer